1,035 Shares in CME Group Inc (NASDAQ:CME) Purchased by Arthur M. Cohen & Associates LLC

Arthur M. Cohen & Associates LLC bought a new position in CME Group Inc (NASDAQ:CME) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,035 shares of the financial services provider’s stock, valued at approximately $219,000.

A number of other institutional investors have also recently made changes to their positions in CME. Buckingham Asset Management LLC lifted its holdings in CME Group by 1.4% during the 2nd quarter. Buckingham Asset Management LLC now owns 3,607 shares of the financial services provider’s stock worth $700,000 after buying an additional 49 shares during the last quarter. IHT Wealth Management LLC raised its position in shares of CME Group by 1.1% during the 2nd quarter. IHT Wealth Management LLC now owns 4,404 shares of the financial services provider’s stock worth $855,000 after purchasing an additional 50 shares during the period. Pitcairn Co. raised its position in shares of CME Group by 2.3% during the 2nd quarter. Pitcairn Co. now owns 2,239 shares of the financial services provider’s stock worth $435,000 after purchasing an additional 51 shares during the period. Lourd Capital LLC raised its position in shares of CME Group by 3.5% during the 2nd quarter. Lourd Capital LLC now owns 1,620 shares of the financial services provider’s stock worth $314,000 after purchasing an additional 55 shares during the period. Finally, Garner Asset Management Corp raised its position in shares of CME Group by 1.1% during the 2nd quarter. Garner Asset Management Corp now owns 5,200 shares of the financial services provider’s stock worth $1,009,000 after purchasing an additional 55 shares during the period. Institutional investors and hedge funds own 84.80% of the company’s stock.

In other news, Director Daniel R. Glickman sold 500 shares of CME Group stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $216.01, for a total transaction of $108,005.00. Following the transaction, the director now directly owns 14,593 shares in the company, valued at approximately $3,152,233.93. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Sean Tully sold 7,200 shares of CME Group stock in a transaction on Friday, September 6th. The shares were sold at an average price of $223.13, for a total value of $1,606,536.00. Following the transaction, the insider now owns 19,923 shares in the company, valued at $4,445,418.99. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,636 shares of company stock worth $3,001,008. 1.20% of the stock is owned by insiders.

CME has been the topic of a number of research reports. Berenberg Bank cut CME Group from a “buy” rating to a “hold” rating and dropped their price target for the stock from $236.00 to $227.00 in a research report on Thursday, September 19th. Wells Fargo & Co increased their price target on CME Group from $200.00 to $205.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. UBS Group dropped their price target on CME Group from $220.00 to $218.00 and set a “neutral” rating on the stock in a research report on Thursday, October 31st. Deutsche Bank increased their price target on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $203.36.

CME opened at $198.17 on Friday. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $224.91. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.05. The stock has a market cap of $70.53 billion, a P/E ratio of 29.06, a P/E/G ratio of 3.86 and a beta of 0.18. The stock’s 50 day moving average price is $208.43 and its 200 day moving average price is $201.58.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 EPS for the quarter, beating the consensus estimate of $1.75 by $0.15. CME Group had a return on equity of 9.54% and a net margin of 40.93%. The firm had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same period last year, the firm earned $1.45 EPS. The firm’s revenue was up 41.3% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc will post 6.91 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Tuesday, December 10th will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.51%. CME Group’s dividend payout ratio is currently 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: Hold Rating

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.